MedTrace Logo

Prospective Assessment of Image Registration for the Diagnosis of Prostate Cancer

NCT02425228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-07-24

No results posted yet for this study

Summary

This is a pilot study to determine cancer detection rate of conventional/systematic versus targeted biopsy methods in diagnosis of potentially lethal prostate cancer. This is a diagnostic trial using each patient as his own control.

Conditions

Interventions

DEVICE

Targeted biopsy

conventional/systematic biopsy, targeted fusion biopsy and cognitive biopsy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-04
Primary Completion
2018-12-18
Completion
2018-12-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02425228 on ClinicalTrials.gov